News

Boston – Four teams of Dana-Farber Cancer Institute investigators have found that people experience discrimination and bias in different ways and in more realms of cancer care than previously understood. The findings, in different studies, suggest that oncology professionals and the systems they work in

Three Huntsman Cancer Institute researchers have recently been recognized for their work as outstanding faculty members at the University of Utah (the U). Credit: Original content Three Huntsman Cancer Institute researchers have recently been recognized for their work as outstanding faculty members at the University of Utah (the U).

A recent study has introduced a novel method combining nano informatics and machine learning to precisely predict cancer cell behaviors, enabling the identification of cell subpopulations with distinct characteristics like drug sensitivity and metastatic potential. This research could transform cancer diagnosis and treatment, enhancing personalized

Immunotherapy represents the new hope in the fight against cancer; however, not all tumors respond to this treatment. Pancreatic cancer is a type of tumor that does not respond to currently approved drugs and is therefore lethal for 9 out of every 10 people diagnosed.

Tumor cells often hijack normal physiological processes to support their growth, exploiting proteins that are in charge of essential cell functions. It is therefore important to block the activity of these proteins only in cancer cells without affecting their crucial roles in healthy tissues. For

According to the WHO, colorectal cancer (CRC) is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases and ranks as the second leading cause of cancer-related deaths worldwide. Credit: BGI Genomics According to the WHO, colorectal cancer (CRC) is the

University of Cincinnati Cancer Center experts will present research at the American Society of Clinical Oncology annual meeting May 31 to June 4 in Chicago. Credit: Photo/University of Cincinnati. University of Cincinnati Cancer Center experts will present research at the American Society of Clinical Oncology

New research out of VCU Massey Comprehensive Cancer Center — recently published in Drug Resistance Updates — revealed a previously unknown biological process through which breast tumor cells develop resistance to standard treatment, which could open the door for cancer scientists around the world to

The European QUSTom project, which under the coordination of the Barcelona Supercomputing Center – Centro Nacional de Supercomputación (BSC-CNS) aims to introduce a new medical imaging modality based on 3D tomographic ultrasound and supercomputing, has begun clinical validation with patients for the early detection of

The review discusses how metabolic cell death, distinct from traditional forms of regulated cell death like apoptosis, arises from imbalances in cellular metabolism due to nutrient and metal overload or depletion. It emphasizes the therapeutic potential of targeting these unique metabolic vulnerabilities in cancer cells,